Pasithea Therapeutics Corp. (KTTA)
NASDAQ: KTTA · Real-Time Price · USD
0.674
-0.016 (-2.30%)
At close: Apr 28, 2026, 4:00 PM EDT
0.700
+0.026 (3.84%)
Pre-market: Apr 29, 2026, 7:23 AM EDT
Pasithea Therapeutics Market Cap
Pasithea Therapeutics has a market cap or net worth of $16.81 million as of April 29, 2026. Its market cap has increased by 337.65% in one year.
Market Cap
16.81M
Enterprise Value
-38.35M
1-Year Change
337.65%
Ranking
Category
Stock Price
$0.67
Market Cap Chart
Since the IPO on September 15, 2021, Pasithea Therapeutics's market cap has decreased from $65.29M to $16.81M, a decrease of -74.25%. That is a compound annual growth rate of -25.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 16.81M | -43.56% |
| Dec 31, 2025 | 29.79M | 646.69% |
| Dec 31, 2024 | 3.99M | -48.26% |
| Dec 29, 2023 | 7.71M | -58.92% |
| Dec 30, 2022 | 18.77M | -51.55% |
| Dec 31, 2021 | 38.74M | -40.66% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cocrystal Pharma | 19.30M |
| Lipocine | 19.02M |
| Passage Bio | 18.32M |
| NewcelX | 17.64M |
| Cadrenal Therapeutics | 17.55M |
| Genenta Science | 17.40M |
| Theriva Biologics | 16.23M |
| Psyence Biomedical | 16.17M |